| Results summary | View all lists in L2L MDB | View all genes in L01AD.profile.u50 |
|
Up-regulated at least 1.4-fold following treatment of HepG2 human hepatocellular carcinoma cells with carcinogen benzo(a)pyrene (BaP), at any time point from 6-48 hours and at any concentration from 0.25-5 microM. enrichment: 34.12-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 221577_X_AT | GDF15 | C | S | growth differentiation factor 15 | |||||||||
| 202922_AT | GCLC | G | X | E | R | glutamate-cysteine ligase, catalytic subunit | |||||||
| 203925_AT | GCLM | X | E | glutamate-cysteine ligase, modifier subunit | |||||||||
| 202923_S_AT | GCLC | G | X | E | R | glutamate-cysteine ligase, catalytic subunit | |||||||
| 209160_AT | AKR1C3 | E | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | ||||||||||
| 219475_AT | OSGIN1 | D | oxidative stress induced growth inhibitor 1 | ||||||||||
| 201266_AT | TXNRD1 | E | S | thioredoxin reductase 1 | |||||||||